Former US congressman Dana Rohrabacher has joined a Colombia-based publicly traded marijuana company as an advisor.

PharmaCielo (TSXV:PCLO) confirmed on Wednesday (May 29) that Rohrabacher has joined the firm as a special advisor.

David Attard, CEO of the company, said in a release that the firm is angling for an entry to the US market by way of cannabidiol (CBD) products.

The executive added that Rohrabacher will serve the company’s US interests thanks to his experience and understanding of the legislative environment in the country.

Rohrabacher said that, after visiting the facilities of the company, he’s “very engaged” in wanting to help the firm navigate US federal and state policy.

Demand and sales for CBD products in the US have grown exponentially following the legalization of hemp and its derivatives.

This regulatory change has led to a race of producers for novelty products using CBD in the health and wellness market.

Investors have gained a variety of options for plays in the CBD craze, especially with the entrance of established retail pharmacies such as CVS Pharmacy (NYSE:CVS) and Walgreens Boots Alliance (NASDAQ:WBA).

“Our team has received accelerated interest from players in several legal US states in recent weeks as the legal structure of medicinal cannabis continues to evolve across the country,” Attard said.

Shares of PharmaCielo were on the rise during Wednesday’s trading session. The company finished the day at a price of C$6.92, representing a 1.17 percent increase in value.

Rohrabacher, a GOP representative, lost his seat in Orange County, California, during the 2018 midterm elections to Democrat Harley Rouda.

He told Cannabis Now in April that he expects to see more involvement from US President Donald Trump regarding the legalization of marijuana in the run up to the 2020 election.

“I think it will all come down to who the nominee is for the Democratic Party,” he said. “If it’s (Joe) Biden, and then we have President Trump talking about being the person that wants to liberalize marijuana laws.”

During his 30 year run in Congress, Rohrabacher was a vocal advocate for cannabis policies and most famously sponsored an amendment to prevent the justice department from pursuing marijuana businesses in legal states with federal funding.

The Rohrabacher-Farr amendment was turned into law in December 2014.

Special hirings of politicians in the cannabis market have become a trend in the space, with fellow Colombian company Khiron Life Sciences (TSXV:KHRN,OTCQB:KHRNF) adding former Mexican president Vicente Fox to its board of directors.

Similarly, former house speaker John Boehner and former Canadian prime minister Brian Mulroney have joined Acreage Holdings (CSE:ACRG,OTCQX:ACRGF) as advisors to the multi-state operator.

PharmaCielo reached the Canadian public markets in January when it completed a reverse takeover to list on the TSX Venture Exchange.

As part of its Q1 2019 financial results, the company pointed to the reverse takeover as the cause of its C$7.7 million net loss during the quarter.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Acreage Holdings and Khiron Life Sciences are clients of the Investing News Network. This article is not paid-for content.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less